Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $346.13 | 11 | 56.2% |
| Education | $269.98 | 3 | 43.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $130.57 | 3 | $0 (2024) |
| Genentech, Inc. | $129.71 | 2 | $0 (2024) |
| Incyte Corporation | $111.14 | 2 | $0 (2022) |
| PUMA BIOTECHNOLOGY, INC. | $89.02 | 1 | $0 (2022) |
| Amgen Inc. | $85.79 | 2 | $0 (2022) |
| Pharmacyclics LLC, an AbbVie Company | $23.65 | 1 | $0 (2022) |
| GENZYME CORPORATION | $19.17 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $14.03 | 1 | $0 (2022) |
| Daiichi Sankyo Inc. | $13.03 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $229.70 | 3 | Genentech, Inc. ($129.71) |
| 2022 | $336.66 | 8 | Incyte Corporation ($111.14) |
| 2021 | $49.75 | 3 | Janssen Biotech, Inc. ($30.58) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2024 | Genentech, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $83.56 | General |
| Category: BioOncology | ||||||
| 06/17/2024 | Genentech, Inc. | Alecensa (Biological) | Food and Beverage | In-kind items and services | $46.15 | General |
| Category: BioOncology | ||||||
| 05/09/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 12/08/2022 | Daiichi Sankyo Inc. | ENHERTU (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: ONCOLOGY | ||||||
| 10/19/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Oncology | ||||||
| 08/09/2022 | PUMA BIOTECHNOLOGY, INC. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $89.02 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2022 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2022 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 06/09/2022 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $12.14 | General |
| Category: Hematology/Oncology | ||||||
| 03/16/2022 | Amgen Inc. | — | Education | In-kind items and services | $70.99 | General |
| 12/04/2021 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Oncology | ||||||
| 11/04/2021 | GENZYME CORPORATION | SARCLISA (Biological), ELITEK | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Oncology | ||||||
| 09/08/2021 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 252 | 455 | $80,028 | $26,905 |
| 2022 | 1 | 199 | 461 | $79,292 | $28,091 |
| 2021 | 1 | 70 | 91 | $15,288 | $5,843 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 252 | 455 | $80,028 | $26,905 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 199 | 461 | $79,292 | $28,091 | 35.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 70 | 91 | $15,288 | $5,843 | 38.2% |
About Heather Jones, APRN, FNP-C
Heather Jones, APRN, FNP-C is a Family healthcare provider based in Olathe, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2020. The National Provider Identifier (NPI) number assigned to this provider is 1245834811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Heather Jones, APRN, FNP-C has received a total of $616.11 in payments from pharmaceutical and medical device companies, with $229.70 received in 2024. These payments were reported across 14 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($346.13).
As a Medicare-enrolled provider, Jones has provided services to 521 Medicare beneficiaries, totaling 1,007 services with total Medicare billing of $60,839. Data is available for 3 years (2021–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Olathe, KS
- Active Since 11/24/2020
- Last Updated 09/21/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1245834811
Products in Payments
- DARZALEX (Biological) $130.57
- Alecensa (Biological) $129.71
- NERLYNX (Drug) $89.02
- IMBRUVICA (Drug) $23.65
- SARCLISA (Biological) $19.17
- Kyprolis (Drug) $14.80
- BLENREP (Biological) $14.03
- ENHERTU (Drug) $13.03
- JAKAFI (Drug) $12.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Olathe
Mrs. Jessica Molstad, Np, NP
Family — Payments: $7,586
Mrs. Heather Conklin, Arnp, ARNP
Family — Payments: $5,196
Amanda Morris, N.p, N.P
Family — Payments: $4,234
Christine Smith, Aprn, APRN
Family — Payments: $4,017
Courtni Parker, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $2,348
Tarryn Gardner
Family — Payments: $1,868